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Purpose: To compare tramadol alone and the combinations of
either tramadol-clonidine or tramadol-droperidol with regard to
analgesic and adverse effects. 
Methods: After Ethic’s Committee approval and patient informed
consent were obtained, epidural catheters were inserted preoper-
atively at the L3–4 interspace in 90 ASA physical status I–II adult
patients undergoing lower abdominal surgery. Anesthesia was stan-
dardized. Patients were randomly assigned to one of three groups.
Group I (T) patients received tramadol 75 mg, Group II (TD)
patients received tramadol 75 mg plus droperidol 2.5 mg, and
Group III (TC) patients received tramadol 75 mg plus clonidine 150
µg in a total volume of 10 mL administered as a single epidural
injection in the postanesthesia care unit. The onset time of analge-
sia and duration of analgesia, visual analogue pain scores, sedation,
nausea scores, vital signs and side effects were recorded.
Results: Duration of analgesia was similar in both the TD and TC
groups, and significantly longer than in the T group (P < 0.001).
Group TC patients displayed a significant increase in sedation scores
and decrease in blood pressure and heart rate when compared
with other groups (P < 0.001). No adverse effects were observed
in Group TD, while nausea scores were high in both the T and TC
groups (P < 0.001). Pain score, respiration rate, and SpO2 values
were similar in all study groups.
Conclusion: We conclude that epidural tramadol in combination
with droperidol or clonidine prolongs the duration of analgesia; how-
ever, droperidol appears to be a better alternative when adverse
effects and antiemetic properties are taken into consideration.
Objectif : Comparer le tramadol à la combinaison de tramadol-cloni-
dine ou de tramadol-dropéridol en regard de leurs effets analgésiques
et indésirables.
Méthode : Ayant obtenu l’approbation du Comité d’éthique et le con-
sentement éclairé des patients, nous avons réalisé l’insertion préopéra-
toire d’un cathéter péridural dans l’espace intercostal L3–4 chez 90
patients adultes d’état physique ASA I–II devant subir une intervention
abdominale basse. L’anesthésie a été normalisée. Les patients ont été
répartis en trois groupes de façon aléatoire. Ceux du groupe I (T) ont
reçu 75 mg de tramadol, ceux du groupe II (TD), 75 mg de tramadol
et 2,5 mg de dropéridol et du groupe III (TC), 75 mg de tramadol plus
150 µg de clonidine dans un volume total de 10 mL administré à la
salle de réveil en une seule injection péridurale. Le délai d’installation
et la durée de l’analgésie, la douleur selon l’échelle visuelle analogique,
la sédation, les nausées, les signes vitaux et les effets secondaires ont
été notés.
Résultats : La durée de l’analgésie a été comparable entre les groupes
TD et TC et significativement plus longue que dans le groupe T (P <
0,001). Les patients du groupe TC, comparés à ceux des autres
groupes, ont connu une hausse significative des scores de sédation et
une baisse de la tension artérielle et de la fréquence cardiaque (P <
0,001). Aucun effet indésirable n’a été observé dans le groupe TD tan-
dis que les scores de nausées ont été plus élevés dans les groupes T et
TC (P < 0,001). Les scores de douleur, la fréquence respiratoire et la
SpO2 ont présenté des valeurs similaires dans tous les groupes de l’étude.
Conclusion : Nous pouvons conclure que l’administration péridurale de
tramadol, combinée au dropéridol ou à la clonidine, prolonge la durée
de l’analgésie ; cependant, le dropéridol semble un meilleur choix quand
on considère les effets indésirables et les propriétés antiémétiques.
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PIDURAL opioid administration is one of
the most common techniques for postoper-
ative pain control. Epidural administration
of low dose opioids provides strong and
long lasting segmental analgesia via opioid receptors.1
However, the known adverse effects of epidural opi-
oids require a very careful selection of the agent and
dosage. Although epidural morphine, fentanyl, alfen-
tanil and pethidine provide effective analgesia and are
associated with a low systemic redistribution, the risk
of respiratory depression increases with repeated and
continuous administration of epidural opioids.
Tramadol may be advantageous because of a low risk
of respiratory depression.2,3 Tramadol is a weak ago-
nist at all types of opioid receptors with some selectiv-
ity for µ receptors. Also, tramadol inhibits the
reuptake of norepinephrine and serotonin, thus
increasing the concentrations of these two neurotrans-
mitters in the central nervous system.
In clinical studies, spinal or epidural administration
of non-opioid agents such as clonidine, droperidol,
neostigmine, ketamine, midazolam, somatostatine and
calcitonin have been shown to provide analgesia with-
out causing motor dysfunction or neurotoxicity.4–8
Epidural droperidol blocks mainly the fast, and to a
lesser extent, the slow sodium channels and inhibits
the formation of action potential. Clonidine, which is
an alpha2 adrenergic agonist, has an anti-nociceptive
effect on a wide dynamic range of neurons and *
receptors. Although they cannot provide sufficient
analgesia by themselves, when used as adjuncts to low-
dose opioids, they decrease adverse effects, and
increase the quality and duration of analgesia.9–14
At present, there is no ideal drug or combination of
drugs for postoperative epidural analgesia. The pre-
sent study was conducted to compare the analgesic
and adverse effects (sedation, nausea, vomiting and
hemodynamic changes) of epidural tramadol used
alone, and the combinations of tramadol-droperidol
and tramadol-clonidine.
Methods
After obtaining approval from the local Ethics
Committee and written informed consent, 90 patients
aged 20–68 yr, ASA physical status I and II, scheduled
for elective total abdominal hysterectomy, were select-
ed for this prospective, randomized and double-blind
study. Randomization was performed by using com-
puter generated random numbers, kept in consecu-
tively numbered and sealed envelopes. Exclusion
criteria were a history of cardiovascular, respiratory, or
central nervous system diseases, bleeding disorders,
use of opioids and drugs that affect the central ner-
vous system (mono amine oxydase inhibitors, carba-
mazepine, quinidine and cimetidine), difficulty of
cooperation and pregnant patients.
All patients were taken into the operating room
unpremedicated. After standard monitoring with non-
invasive blood pressure, electrocardiography and
peripheral oxygen saturation (SpO2), administration of
Lactated Ringer’s solution was started. Patients were
positioned in the lateral decubitus and a 20-G epidural
catheter (Perifix 401, B.Braun, Melsungen AG) was
inserted through an 18-gauge Tuohy needle at the L3–4
interspace. The same anesthesiologist (E.G.) inserted all
epidural catheters. After injection of 2 mL 0.5% bupiva-
caine with 15 µg adrenalin through the epidural
catheter as a test dose, the catheter was fixed and the
patient was repositioned supine. Induction of anesthe-
sia was achieved with propofol (2 mg·kg–1) and cis-
atracurium (0.2 mg·kg–1). The trachea was intubated
and the lungs ventilated mechanically. Anesthesia was
maintained with an O2/N2O mixture (50%:50%),
isoflurane and cis-atracurium.
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E TABLE I Sedation scores150 Alert or drowsy but easily aroused to an alert state by verbal commands alone1 Sleeping and arousable by verbal commands
2 Sleeping and not aroused by verbal stimuli, but aroused to a 
drowsy state by tactile stimulation
3 Sleeping and not aroused to a drowsy state by tactile 
stimulation
TABLE II Nausea and vomiting scores16
0 No nausea/vomiting
1 Mild nausea/vomiting (patient not requesting an antiemetic)
2 Nausea/vomiting patient requesting an antiemetic
3 Nausea/vomiting, resistant to antiemetic
TABLE III Demographic data and duration of surgery (mean ± SD)
T (n = 30) TD (n = 30) TC(n = 30)
Age (year) 53.8 ± 9.4 51.3 ± 9.1 52.3 ± 8.9 
Body weight (kg) 64.5 ± 10.8 63.5 ± 10.5 64.7 ± 11.0
Length (cm) 162.4 ± 12.4 160.2 ± 11.9 164.1 ± 12.0
Sex (M/F) 14/16 12/18 15/15
ASA (I/II) 30/0 28/2 28/2
Duration of 
surgery (min) 92.5 ± 9.0 91.9 ± 8.8 92.7 ± 9.3
T = tramadol alone; TD = tramadol-droperidol; TC = tramadol-
clonidine.
After surgery, patients were admitted to the
postanesthetic care unit. They were randomly assigned
to one of three groups when they stated having pain
and were hemodynamically stable. Group I (T)
patients received tramadol 75 mg, Group II (TD)
received 75 mg tramadol plus 2.5 mg droperidol, and
Group III (TC) received 75 mg tramadol plus 150 µg
clonidine in a total volume of 10 mL administered as
a single epidural injection by an investigator blinded
to study group.
The intensity of postoperative pain was measured
with the visual analogue scale (VAS). Sedation was
monitored on a four-point scale (Table I)15 and nau-
sea was monitored on a four-point scale (Table II).16
The onset time of analgesia, duration of analgesia and
total tramadol dose were recorded. The onset time of
analgesia was defined as the time required to decrease
the VAS score control value by 20 mm, and duration
of analgesia as the increase of VAS score value by 20
mm. The need for additional tramadol or TC/TD was
defined as an increase in the VAS pain score of 20 mm
or more. Total tramadol consumption during the last
24 hr is reported in all patients. Vital signs (respirato-
ry rate, SpO2, heart rate, blood pressure), sedation
and nausea scores, VAS pain scores and adverse effects
were assessed before injection, and at five, ten, 20, 30
min, one, two, three, four, five, six, eight, 12, 16, 20,
and 24 hr after epidural injection. In cases of VAS
scores  5 cm at rest 30 min after epidural injection,
patients were given 1 mg·kg–1 meperidine im. When
nausea and vomiting were $ 2, patients were given
metoclopramide 10 mg iv. Hypotension, defined as a
reduction of the systolic blood pressure > 20%, was
treated with the rapid infusion of lactated Ringer’s
solution and iv boluses of ephedrine. All postoperative
assessments were made by an investigator blinded to
study group.
Previous studies have determined that the effective
dose of epidural tramadol for postoperative analgesia
ranges from 75 to 200 mg. With a level of α 0.05 and
ß level of 0.2, power analysis indicated that 30 observa-
tions would be needed to detect clinically relevant dif-
ferences in tramadol consumption. A 50% decrease in
the tramadol consumption in the treatment groups
would be of clinically relevance.17 Intergroup compari-
son of demographic data was made by Student’s t test.
The three groups were compared by Mann Whitney U
test for non-parametric data. Comparison was made by
one-way analysis of variance (ANOVA) followed by a
Student’s t test for parametric data. Results were
expressed as mean ± standard deviation. A value of P <
0.05 was considered statistically significant.
Results
The three groups of patients were similar with respect
to demographic data, ASA physical status and dura-
tion of surgery (Table III). The onset time of analge-
sia was 16.8 ± 2.1 min, 8.3 ± 1.1 min, and 8.7 ± 1.2
min in the T, TD, and TC groups, respectively. It was
longer in the T group than in the TD and TC groups
(P < 0.001). Patients in the T group displayed short-
er durations of analgesia than in the other groups (4.1
± 2.1 hr, 15.4 ± 4.1 hr, and 14.9 ± 4.2 hr in T, TD,
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FIGURE 1 Onset time and duration of analgesia and tramadol
consumption in number of doses required in 24 hr.
FIGURE 2 Visual analogue scale (VAS) after surgery.
and TC groups respectively; P < 0.001). Tramadol
consumption (doses per day) was higher in the T
group than in the TD and TC groups (P < 0.001).
Tramadol consumption was 457.5 ± 16.7 mg, 90 ±
8.2 mg, and 82.5 ± 8.9 mg in the T, TD and TC
groups respectively (Figure 1).
VAS pain scores in the T group were significantly
higher when compared with the other groups at four,
eight, 12, 20 and 24 hr (P < 0.001). No difference
was found for the VAS score at the 16th hr. No patient
required meperidine (Figure 2).
Group T and TD patients did not show any seda-
tion, however group TC patients had increased seda-
tion scores at ten minutes (Figure 3; P < 0.001).
Patients in the T and TC groups had higher nausea
scores than those in the TD group at ten minutes (P
< 0.001; Figure 3). There was no statistical significant
difference for nausea/vomiting and sedation scores at
the other time points. The incidence of nausea and
vomiting ten minutes after epidural injection was 24%,
0.1%, and 22% in the T, TD and TC groups respec-
tively. Six patients in the T group and seven patients in
the TC group received metoclopramide for nausea
and vomiting.
Blood pressure and heart rate were not different
from control in the T and TD groups. Patients in the
TC group showed a decrease of 10% (P < 0.01) in
blood pressure and of 6% (P < 0.05) in heart rate
beginning ten minutes after injection until the end of
the study (Figure 4). Respiratory rate and SpO2 values
were within normal ranges in all patients.
Discussion
Mean onset time of analgesia has been reported as
10–15 min for epidural tramadol and 5–11 min for the
tramadol-droperidol combination.2,16,18 Furthermore,
it has been stated that a combination of clonidine with
fentanyl, sufentanil and morphine decreases the onset
time of analgesia by 50%.4,19,20 Consistent with previous
reports, the present study shows that the onset time of
analgesia was 16 min time with tramadol alone and that
this time decreased to approximately eight minutes
when either clonidine or droperidol was added.
The mean durations of analgesia have been report-
ed as being four to six hours for tramadol alone and
12–16 hr for the tramadol-droperidol combination,
where the number of daily doses were six to eight for
the tramadol alone and one to two for the tramadol-
droperidol combination.2,9,16 It has been suggested
that the combination of clonidine with an opioid
extends the duration of analgesia by two to three
times.1,4,10,15,21 Murthy et al.22 have found a lower vol-
ume of distribution for epidural tramadol and stated
that the half-life was shorter than with iv usage. In the
present study, we observed that the addition of cloni-
dine or droperidol to tramadol extends the duration of
analgesia by three times on average and, consequent-
ly, reduces daily tramadol requirements.
Studies using tramadol and tramadol-droperidol
combinations found no significant sedation,2,3,9,16,18
while all studies using clonidine have reported a
prominent increase in sedation.1,4,10,15,19 This leads us
to believe that the significant increase in sedation
observed in the tramadol-clonidine group was due to
the addition of clonidine.
Although the studies using epidural clonidine have
reported bradycardia and hypotension as the most fre-
quent adverse effects,1,4,10,15,19 no significant hemody-
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FIGURE 3 Sedation and nausea/vomiting scores ten minutes
after epidural injection.
FIGURE 4 Systolic blood pressure and heart rate in the postop-
erative period (mean ± SD).
namic adverse effects have been reported with tra-
madol alone or with the tramadol-droperidol combi-
nation.1–3,12,16,18 We observed a decrease in blood
pressure and heart rate from the tenth minute
onwards only in the tramadol-clonidine group. This
decrease did not require any intervention and no such
adverse effect was detected in the other groups.
Low plasma concentrations of tramadol are observed
after epidural injection, and these are insufficient to
produce an analgesic effect.2 Therefore, despite the lack
of a parenteral control group, we believe that the anal-
gesic effect of tramadol was mediated epidurally.
The most frequent side effect of epidural tramadol
is nausea. The addition of droperidol to epidural opi-
oids has a strong antiemetic effect.1,4,15,23 In the pre-
sent study, nausea was the most frequent adverse effect
in the tramadol and tramadol-clonidine groups and,
since no significant difference was detected between
the two groups, we conclude that nausea is probably
secondary to tramadol. The absence of nausea in the
tramadol-droperidol group is consistent with previous
studies and might be related to the antiemetic effect of
droperidol.
The main adverse effects of long-term epidural
droperidol are sedation, anxiety, panic, suicide and
extrapyramidal side effects.1 When used per oral, iv or
epidural, droperidol has shown adverse effects such as
QT prolongation and/or arrhythmia.24–26 The
absence of adverse effects in the present study may be
secondary to the brief duration of exposure, the low
doses used and the small number of patients studied.
The safety of epidural and intrathecal clonidine has
been established in several studies.1,10 No local or sys-
temic toxic effects of epidural droperidol have been
reported except for excessive sedation.1,8,12 Finally, no
systemic or local neurotoxicity has been reported with
the epidural injection of tramadol.1–3,6
In conclusion, our results suggest that the addition
of droperidol or clonidine to epidural tramadol pro-
vides a shorter onset time and a longer duration of
analgesia. Droperidol seems to be a more suitable
adjunct when its adverse effects and antiemetic prop-
erties are taken into consideration.
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